Predictive value of ACR core set parameters for the development of rheumatoid arthritis in patients with positive anti-cyclic citrullinated peptide antibodies and undifferentiated arthritis

Rheumatology (Oxford). 2014 Jul;53(7):1347-8. doi: 10.1093/rheumatology/keu160. Epub 2014 May 8.

Authors

Laurent Meric de Bellefon¹, Frédéric Houssiau¹, Genevieve Depresseux¹, Adrien Nzeusseu Toukap¹, Bernard Lauwerys¹, Patrick Durez²

Affiliations

¹ Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
² Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. patrick.durez@uclouvain.be.

PMID: 24811973
DOI: 10.1093/rheumatology/keu160

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Anti-Idiotypic / blood*
Arthritis / blood
Arthritis / epidemiology*
Arthritis / immunology
Arthritis, Rheumatoid / blood
Arthritis, Rheumatoid / epidemiology*
Arthritis, Rheumatoid / immunology*
Biomarkers / blood
Cohort Studies
Comorbidity
Endpoint Determination
Female
Follow-Up Studies
Humans
Male
Middle Aged
Peptides, Cyclic / immunology*
Predictive Value of Tests
Prospective Studies
Risk Factors
Sensitivity and Specificity

Substances

Antibodies, Anti-Idiotypic
Biomarkers
Peptides, Cyclic
cyclic citrullinated peptide